Dyadic International Inc, DE

DYAINASDAQ · USD
0.29USD0.00 (-7.66%)
132

Dyadic International Inc, DE (DYAI) Historical Volatility

DYAI's 30 day historical volatility is 79.59%, in the 61st percentile of readings over the past year. This is an average percentile, meaning Dyadic International Inc, DE shares have moved roughly in line with their typical range. DYAI's 30 day implied volatility sits at 705.66%, with an IV Rank of 75.79%, leaving IV 626.07 points above historical volatility. This means options are pricing in more movement than the stock has actually delivered, as of Nov 20, 2026.

Read more

Tracking DYAI historical volatility helps you see how much Dyadic International Inc, DE's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, DYAI's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor DYAI 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. DYAI's 30 day historical volatility, or DYAI HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing DYAI's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates.

Historical Volatility

HV Percentile
61stHV Percentile
Moderate

Historical movement is near its typical level for the past year. Neither unusually calm nor unusually active.

Historical Volatility (30d)79.59%

HV Percentile61st

Implied Volatility (30d)705.66%

IV Rank75.79%

IV Minus HV+626.07%

As of Nov 20, 2026

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of Nov 20, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →